A comprehensive screening process identified 23 immune cell types with notable distribution changes in tumor samples compared to the normal group (Figure 2A), such as, fibroblasts, memory B cells, CD56bright NK cells, activated CD4 T cells, NK cells, immature DCs, and others. The gene discussed is CD4; the disease is neoplasm.